Evidence map›Paper›PMID 40870868›Full record

ReviewDiagnostics (Basel, Switzerland)2025

Recent Advances in Magnetic Resonance Imaging for the Diagnosis of Liver Cancer: A Comprehensive Review.

Faisal Alshomrani

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Hybrid FeInternational journal of molecular sciences · 2026
    Article
  3. Liquid Biopsy-Based Profiling ofInternational journal of hepatology · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Faisal AlshomraniDepartment of Diagnostic Radiology Technology, College of Applied Medical Science, Taibah University, Medinah 41477, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MRI is a non-invasive imaging technique employed today in modern diagnostic medicine due to the fact it is capable of generating tissue architecture and function information with high image resolution without the use of ionizing radiation, unlike x-ray or CT scans. The advantages of MRI discussed in this review include better soft tissue contrast, the opportunity to perform imaging in different planes, and the ability to detect small changes in tissues, which helps to use MRI in many specialties, including cancer diagnosis and staging, as well as neurological and cardiovascular diseases. More particularly, this review aims to assess the contribution of MRI to the detection of liver cancer, especially HCC and ICC-the most frequent and aggressive types of pathology. Because of its high-resolution, MRI provides clear visualization of the small hepatic lesion and vascular mapping, which is crucial for early diagnosis and staging. It also reveals higher sensitivity and specificity than ultrasound and CT in identifying liver cancer dimensions and relations with system vasculature and a safer technique for patients who need many follow-up images. This is in addition to newer techniques that have been developed from MRI, which include the DWI, DCE-MRI, and MRE, all of which yield functional information concerning the perfusion of the tumor and the stiffness of the tissue, respectively, thus improving the diagnosis. Moreover, the application of artificial intelligence to MRI is improving lesion identification and cancer assessment, as well as patient outcome prediction, while relieving the burden of radiologists. Suggested improvements for future work include the combination of MRI with other diagnostic approaches, including circulating cell analysis and molecular imaging in managing liver cancer. Still, there is a limitation in MRI's access globally, because scanners are expensive and unavailable in some parts of the world. Technological improvements and greater availability will extend MRI more as a valuable modality in the treatment of liver malignancies, more so for diagnosis and staging.

Indexed as

diagnosishepatocellular carcinomaimaging biomarkersliver cancermagnetic resonance imagingradiomics

Identifiers

PMID40870868
PMCPMC12386106

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.